Today, the European Commission has published our study on the economic impact of supplementary protection certificates, pharmaceutical incentives and rewards in Europe.
Using a novel measure of ‘Effective protection period’ as well as a unique, new dataset we assess the economic impact of supplementary protection certificates (SPC’s) and the pharmaceutical incentives and rewards in the EU.
For further information, please contact Christian Jervelund